Success Metrics

Clinical Success Rate

60.0%

Based on 6 completed trials

Completion Rate

60%(6/10)

Active Trials

3(21%)

Results Posted

50%(3 trials)

Terminated

4(29%)

Phase Distribution

Ph phase_2

50%

Ph phase_3

43%

Ph phase_1

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution14 total trials

Phase 1Safety & dosage

1(7.1%)

Phase 2Efficacy & side effects

7(50.0%)

Phase 3Large-scale testing

6(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

60.0%

6 of 10 finished

Non-Completion Rate

40.0%

4 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Completed(6)

Terminated(4)

Other(1)

Detailed Status

Completed6

Terminated4

Recruiting2

Active, not recruiting1

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

60.0%

Most Advanced

Phase 3

Trials by Phase

Phase 11 (7.1%)

Phase 27 (50.0%)

Phase 36 (42.9%)

Trials by Status

active_not_recruiting17%

unknown17%

completed643%

terminated429%

recruiting214%

Recent Activity

3 active trials

Showing 5 of 14

active_not_recruitingphase_2

EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer

NCT04465500

recruitingphase_2

Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas

NCT05419518

recruitingphase_2

Clinical Trials (14)

Showing 14 of 14 trials

NCT04465500Phase 2

EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer

Active Not Recruiting

NCT05419518Phase 2

Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas

Recruiting

NCT02297217Phase 2

Chemoradiotherapy for Advanced Esophageal Cancer

Recruiting

NCT00186888Phase 3

Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma

Completed

NCT04159155Phase 2

A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer

Terminated

NCT04357587Phase 1

Safety and Feasibility of PD-1 Blockade in the Treatment of dMMR or MSI-H Rectal Cancer

Completed

NCT02028988Phase 2

Enzalutamide + External Beam Rt For Prostate

Completed

NCT01900327Phase 3

Neoadjuvant Treatment in Resectable Pancreatic Cancer

Terminated

NCT03332069Phase 3

Modulated Electro-Hyperthermia Plus Chemo-radiation for Locally Advanced Cervical Cancer Patients in South Africa

Unknown

NCT01060007Phase 2

Five Fractions of Radiotherapy Followed by Full Dose FOLFOX Chemotherapy as Preoperative Treatment for Rectal Cancer

Completed

NCT00243646Phase 3

Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial

Terminated

NCT00241384Phase 3

Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer

Completed

NCT00242203Phase 2

Evaluation of Chemotherapy Prior to Surgery With or Without Zometa for Women With Locally Advanced Breast Cancer

Completed

NCT00269165Phase 3

Adjuvant Radiation in Aortic Valvuloplasty - ARAVA

Terminated

All 14 trials loaded

Drug Details

Intervention Type: RADIATION
Total Trials: 14